Gene · 5313
NIH grants1,543
NIH grants whose papers are about the gene, through NIH's grant-paper links.
601 to 620 of 1,543
Download this page as JSON| Grant | Title | PKLR papers | Newest fiscal year |
|---|---|---|---|
| UH3DK114923 | Nephron Sub-segmental Omics and Quantitative 3D Imaging of Human Kidney. | 1 | 2021 |
| UM1AI068615 | Statistical and Data Management Center (SDMC): Microbicide Trials Network | 1 | 2021 |
| UM1AI068633 | Leadership and Operations Center (LOC): Microbicide Trials Network | 1 | 2021 |
| UM1AI106707 | Laboratory Center (LC): Microbicide Trials Network | 1 | 2021 |
| UM1HG009393 | High-throughput functional characterization of human enhancers | 1 | 2021 |
| UM1HG009409 | Comprehensive Mapping of Long-Range Chromatin Interactions in Humanand Mouse Genomes | 1 | 2021 |
| ZIAAG000675 | Aging-related Traits and Disease Risk Factors in a Sardinian Population Cohort | 1 | 2021 |
| ZIADK069000 | Epidemiology of Type 2 Diabetes Mellitus in the Gila River Indian Community | 1 | 2021 |
| ZIAES103349 | Molecular Pathogenesis of Rodent Neoplasia | 1 | 2021 |
| ZICES103316 | Toxicological Assessments for the Division of the National Toxicology Program | 1 | 2021 |
| ZICES103319 | Toxicologic Pathology Evaluations for the Division of the National Toxicology Program | 1 | 2021 |
| R01GM025232 | Coordinate Gene Regulation in Animal Cells | 3 | 2020 |
| R01GM114409 | Functional Annotation of Natural and Disease Variants in Tryosine Kinases | 3 | 2020 |
| K24HL132008 | Research and Mentoring in Comparative Effectiveness and Implementation Science | 2 | 2020 |
| P01AI118688 | Disruption of T cell tolerance in type 1 diabetes | 2 | 2020 |
| P01CA062220 | Integrated EGFR function in cytokine-driven inflammation and cancer | 2 | 2020 |
| P30ES002109 | MIT Center for Environmental Health Sciences | 2 | 2020 |
| R01DK108905 | ChREBP Isoforms in Pancreatic Beta Cells | 2 | 2020 |
| R01GM118589 | Towards exome analyses: Surprising outcomes from mutating nonconserved positions | 2 | 2020 |
| R37DK050107 | Transcriptional Control of Hemoglobin Synthesis | 2 | 2020 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5313/grants?page=31